This brief covers the trailing ~72 hours (October 26–28, 2026). Every item below was confirmed on the originating organization’s own page.
Anthropic files S-1 for a proposed initial public offering
Anthropic · October 26, 2026
Anthropic, PBC has filed a Form S-1 registration statement with the U.S. Securities and Exchange Commission for a proposed IPO of its Class A common stock. The company plans to list on the Nasdaq Global Select Market, though the number of shares and price range have not yet been set.
“Anthropic intends to list its Class A common stock on the Nasdaq Global Select Market under the symbol ‘ANT.'” — Anthropic
Source: Anthropic files S-1 with the SEC for proposed initial public offering
OpenAI releases GPT-6.1 Terra, with a Critical cybersecurity rating
OpenAI · October 26, 2026
OpenAI published a system card addendum for GPT-6.1 Terra, a fast model aimed at high-volume professional work. OpenAI rates it Critical for cybersecurity and High for biological and chemical capabilities, applying the same safeguards used for GPT-6.1 Sol and GPT-6 Astra. Safety results are mixed: gains on under-18 content and some health benchmarks, regressions on hate and extremism evaluations and some mental health benchmarks.
“a fast, efficient model for high-volume professional work” — OpenAI
Source: Addendum to GPT-6 Astra System Card: GPT-6.1 Terra
Google DeepMind previews Genie 4, a real-time world model with native audio
Google DeepMind · October 27, 2026
Genie 4 generates interactive simulated scenes in real time, with improved physics and more natural human motion. Gemini models help steer scenes and keep them coherent. It is a research preview for trusted testers, with broader access planned for Google AI Ultra subscribers and early-access API partners.
“Genie 4 is our first real-time world model to generate audio natively.” — Google DeepMind
Source: Genie 4: a new generation of world simulation
Anthropic expands its GSA partnership with a 40% government discount
Anthropic · October 27, 2026
Anthropic is offering government customers a 40% discount on Claude products across all purchasing channels, plus a support program to help agencies implement Claude. The company estimates the discounts would save the government about $1 billion.
“Agencies are not bound by a minimum spend commitment and will be able to pay for the usage they consume.” — Anthropic
Source: Expanding our partnership with GSA to bring Claude to all levels of government
Anthropic reports early progress on drug development with Claude
Anthropic · October 27, 2026
Anthropic shares early results from partnerships with six drug developers and its own research programs, with Claude supporting work from molecule design to manufacturing documentation. The work is still mostly preclinical, and the company plans to expand it significantly.
“There is no single problem to solve; the bottlenecks are distributed all throughout the drug development process.” — Anthropic
Source: Early progress on accelerating drug development with Claude
This brief covers the trailing ~72 hours (October 26–28, 2026).
Primary sources: